Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250)

Sam Chun Dang Pharm. Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	246,055	231,805	210,924	192,669	177,335	167,275
Revenue Growth	15.47%	9.90%	9.47%	8.65%	6.01%	0.25%
Gross Profit Gross Profit Growth	116,128	109,091	99,285	96,605	89,630	82,835
Operating Income Operating Income Growth	13,186	8,325	2,563	9,560	12,569	-15,289
Net Income Net Income Growth	10,232	5,262	-10,916	-10,383	5,838	-16,555
Earnings Per Share EPS Growth	438.83	226.24	-474.00	-463.03	264.52	-750.19
EPS Growth	-	-	-	-	-	-

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	110,369	129,058	141,917	92,744	86,248	102,025
Total Debt Total Debt Growth	48,724	69,831	49,941	53,625	76,590	51,541
Net Cash (Debt) Net Cash Growth	61,645	59,227	91,975	39,119	9,658	50,484
Net Cash Growth	-20.42%	-35.61%	135.12%	305.04%	-80.87%	-32.59%
Net Cash Per Share Net Cash Per Share Growth	2647.35	2546.56	3993.76	1718.95	437.65	2287.64

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	-1,129	9,793	21,771	23,428	13,279	-7,707
Capital Expenditures CapEx Growth	-51,911	-46,146	-17,022	-6,766	-16,531	-14,882
Free Cash Flow Free Cash Flow Growth	-53,040	-36,353	4,748	16,662	-3,252	-22,589
Free Cash Flow Growth	-	-	-71.50%	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	47.20%	47.06%	47.07%	50.14%	50.54%	49.52%
Operating Margin	5.36%	3.59%	1.21%	4.96%	7.09%	-9.14%
Pretax Margin	7.88%	5.40%	5.23%	-2.36%	5.03%	-11.69%
Profit Margin	4.16%	2.27%	-5.17%	-5.39%	3.29%	-9.90%
FCF Margin	-21.56%	-15.68%	2.25%	8.65%	-1.83%	-13.50%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 21, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	385.93	1027.68	-	-	165.58	-
Forward PE	-	111.99	111.99	111.99	111.99	111.99
P/FCF Ratio	-	-	727.36	105.58	-	-
PS Ratio	16.05	23.33	16.37	9.13	5.45	5.72

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 21, 2026

Data Sources Report a data error